Litigation Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
✉ Email this page to a colleague
SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-07-06 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | Plaintiff | Referred To | Mark Falk |
| Patents | 6,063,927; 6,113,944; 6,172,233; 7,598,271; 8,658,663; 8,946,251; 9,393,237 | ||
| Link to Docket | External link to docket | ||
Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-07-10 | 11 | HOLDER or l'ATENT OR TRADEMARK. I us 9,393,237 7/19/2016 … ~ 0 Trademarks or ~Patents. ( O the patent action involves 35 U.S.C. § 292.): DOCKET… AO120 Patent Form filed. (jr) (Entered: 07/10/2017) 10 July 2017 PACER Document … REPORT ON THE Director of the U.S. Patent and Trademark Office … ACTION REGARDING A PATENT OR Alexandria, VA 22313 | External link to document | |
| 2017-07-20 | 22 | paroxetine derivatives are is disclosed in US 6,063,927. US 6,440,459 and US 2004/0143120 disclose paroxetine…ANDERSEN ET AL. !S.K./ A15 US-6,063 927 5/16/2000 …issue date of the patent, and will include the patent term adjustment on the patent. Any request for reconsideration…infringes Plaintiff’s U.S. Patent Nos. 5,874,447 (“’447 patent”); 7,598,271 (“’271 patent”); 8,658,663…,663 (“’663 patent”); and 8,946,251 (“’251 patent”) (collectively “patents-in-suit”) under 35 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
